Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Net Cash Flow: 2009-2024

Historic Net Cash Flow for Assembly Biosciences (ASMB) over the last 16 years, with Dec 2024 value amounting to $18.5 million.

  • Assembly Biosciences' Net Cash Flow fell 115.92% to -$1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.9 million, marking a year-over-year decrease of 429.51%. This contributed to the annual value of $18.5 million for FY2024, which is 156.80% up from last year.
  • Per Assembly Biosciences' latest filing, its Net Cash Flow stood at $18.5 million for FY2024, which was up 156.80% from -$32.6 million recorded in FY2023.
  • In the past 5 years, Assembly Biosciences' Net Cash Flow registered a high of $18.5 million during FY2024, and its lowest value of -$32.6 million during FY2023.
  • Its 3-year average for Net Cash Flow is -$2.4 million, with a median of $6.8 million in 2022.
  • Per our database at Business Quant, Assembly Biosciences' Net Cash Flow tumbled by 579.71% in 2023 and then surged by 156.80% in 2024.
  • Assembly Biosciences' Net Cash Flow (Yearly) stood at $12.7 million in 2020, then tumbled by 208.69% to -$13.8 million in 2021, then surged by 149.15% to $6.8 million in 2022, then plummeted by 579.71% to -$32.6 million in 2023, then spiked by 156.80% to $18.5 million in 2024.